Data supports LR 09 as a vital checkpoint inhibitor for treating leukaemia patients
Laevoroc announces promising purine nucleoside phosphorylase data
by FMR Global | Dec 15, 2022 | FMR GLOBAL | 0 comments
by FMR Global | Dec 15, 2022 | FMR GLOBAL | 0 comments
Data supports LR 09 as a vital checkpoint inhibitor for treating leukaemia patients